References
- Masaki N, etal. Ten-year follow-up of familial hypercholester-olemia patients after intensive cholesterol-lowering therapy. hit Heart J 2005;46(5):833–843.
- Bröijersen A, et al. Effects of selective LDL-apheresis and pravastatin therapy on platelet function in familiar hyperch-olesterolaemia. Eur J Clin Invest 1994;24:488–498.
- Thompson GR, et al. Plasma exchange in the management of familial hypercholesterolemia . Lancet 1975;305 (7918): 1208–1211.
- Blaha M, et al. Selectins and monocyte chemotactic peptide as the markers of atherosclerosis activity. Physiol Res 2004; 53:273–278.
- Blaha M, et al. Activity of thrombocytes as a marker of sufficient intensity of LDL-apheresis in familial hypercholes-terolaemia. Transfus Apheresis Sci 2004;30(2):83–87.
- Vojacek J, et al. Arterial and venous thrombosis (In Czech) Grada, Praha 2004. ISBN 80-247-0501-X p 276.
- Kvasnicka J, et al. Thrombophilia and thrombotic events in clinical practice (In Czech) Grada, Praha 2003, ISBN 80-7169-993-4 p 299.
- Gordon BR, et al. Indications for low-density lipoprotein apheresis. Am J Cardiol 1994;74:1109–1112.
- Blaha V, et al. Selective criteria for treatment of severe familial hypercholesterolemia with LDL-apheresis (In Czech). Cas Lék 6es 1998; ro6. 137(6. 14):424–429.
- Zivny P, et al. List of laboratory methods available in University Hospital Hradec Kralove (In Czech) ATD, Hradec Králové 1997 p 147.
- Cermanova M, et al. LDL-aphersis—evaluation of 1000 therapeutic procedures (In Czech). Transfuze a hematologie dnes 2005;11(3):116–121.
- Blazek M, et al. Changes of metabolism and hemostasis in familial hypercholetsrolemia treated with LDL-apheresis (In Czech), Nucleus HK, Hradec Kralove 2007, 136 pp. ISBN 978-80-87009-16–1.